Article Text

other Versions

PDF
Treatment of painful hypertrophic osteoarthropathy associated with non-small cell lung cancer with octreotide: a case report and review of the literature
  1. Elizabeth Birch,
  2. Debbie Jenkins and
  3. Simon Noble
  1. Department of Palliative Medicine, Royal Gwent Hospital, Newport, UK
  1. Correspondence to: Simon Noble, Department of Palliative Medicine, Royal Gwent Hospital, Cardiff Rd, Newport NP20 2UB, UK; simon.noble{at}wales.nhs.uk

Abstract

Hypertrophic osteoarthropathy (HOA) is a syndrome most commonly associated with non-small cell lung cancer and consists of periostitis, digital clubbing and painful polyarthropathy. Its symptoms may be disabling and are reportedly difficult to manage effectively with conventional analgesia. We present a case of a lung cancer patient with opioid resistant painful HOA in whom analgesia was achieved with octreotide.

  • Accepted 5 July 2011.

Statistics from Altmetric.com

  • Accepted 5 July 2011.
View Full Text

Footnotes

  • Competing interests None.

  • Patient consent Obtained

  • Provenance and peer review Not commissioned; externally peer reviewed

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.